Johnson & Johnson (JNJ) vs Tesla, Inc. (TSLA)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Tesla, Inc. is a vertically integrated battery electric vehicle manufacturer and developer of real-world artificial intelligence software, including autonomous driving technology and humanoid robots. Its vehicle lineup includes luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to launch a sports car and introduce a robotaxi service. In 2025, the company delivered nearly 1.64 million vehicles globally. Beyond automotive operations, Tesla sells batteries for stationary energy storage across residential, commercial, and utility applications, along with solar panels and solar roofs for power generation. The company also operates a fast-charging network and an auto insurance business.